Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Foster

Showing results (1231-1240 of 1,276) with videos related to

Pageof 128
Sort By:
Nature Communications|September 14, 2019
GSTA4 mediates reduction of cisplatin ototoxicity in female miceHyo-Jin Park, Mi-Jung Kim, Christina Rothenberger, et al.
Haematologica|May 30, 2015
Randomized multicenter phase II study of flavopiridol (alvocidib), cytarabine, and mitoxantrone (FLAM) versus cytarabine/daunorubicin (7+3) in newly diagnosed acute myeloid leukemiaJoshua F Zeidner, Matthew C Foster, Amanda L Blackford, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|September 25, 2016
Non-GFR Determinants of Low-Molecular-Weight Serum Protein Filtration Markers in CKDXun Liu, Meredith C Foster, Hocine Tighiouart, et al.
The Journal of Trauma and Acute Care Surgery|March 24, 2022
Sex differences associate with late microbiome alterations after murine surgical sepsisPhilip Alexander Efron, Dijoia B Darden, Eric C Li, et al.
Psychotherapy and Psychosomatics|December 6, 2021
Treating Insomnia with High Risk of Depression Using Therapist-Guided Digital Cognitive, Behavioral, and Circadian Rhythm Support Interventions to Prevent Worsening of Depressive Symptoms: A Randomized Controlled TrialJeanne Leerssen, Oti Lakbila-Kamal, Laura M S Dekkers, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 2, 2001
A soluble class II cytokine receptor, IL-22RA2, is a naturally occurring IL-22 antagonistW Xu, S R Presnell, J Parrish-Novak, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 30, 2021
Clinical Activity of Single-Agent Cabozantinib (XL184), a Multi-receptor Tyrosine Kinase Inhibitor, in Patients with Refractory Soft-Tissue SarcomasGeraldine O'Sullivan Coyne, Shivaani Kummar, James Hu, et al.
Kidney Medicine|August 1, 2020
Development and Validation of Residual Kidney Function Estimating Equations in Dialysis PatientsDominik Steubl, Li Fan, Wieneke M Michels, et al.
Leukemia|January 5, 2020
Immunomodulation with pomalidomide at early lymphocyte recovery after induction chemotherapy in newly diagnosed AML and high-risk MDSJoshua F Zeidner, Hanna A Knaus, Amer M Zeidan, et al.
Blood Advances|January 26, 2021
Comparison of CALGB 10403 (Alliance) and COG AALL0232 toxicity results in young adults with acute lymphoblastic leukemiaAnjali S Advani, Eric Larsen, Kristina Laumann, et al.
Pageof 128

Showing results (1231-1240 of 1,276) with videos related to

Sort By:
Pageof 128
Nature Communications|September 14, 2019
GSTA4 mediates reduction of cisplatin ototoxicity in female miceHyo-Jin Park, Mi-Jung Kim, Christina Rothenberger, et al.
Haematologica|May 30, 2015
Randomized multicenter phase II study of flavopiridol (alvocidib), cytarabine, and mitoxantrone (FLAM) versus cytarabine/daunorubicin (7+3) in newly diagnosed acute myeloid leukemiaJoshua F Zeidner, Matthew C Foster, Amanda L Blackford, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|September 25, 2016
Non-GFR Determinants of Low-Molecular-Weight Serum Protein Filtration Markers in CKDXun Liu, Meredith C Foster, Hocine Tighiouart, et al.
The Journal of Trauma and Acute Care Surgery|March 24, 2022
Sex differences associate with late microbiome alterations after murine surgical sepsisPhilip Alexander Efron, Dijoia B Darden, Eric C Li, et al.
Psychotherapy and Psychosomatics|December 6, 2021
Treating Insomnia with High Risk of Depression Using Therapist-Guided Digital Cognitive, Behavioral, and Circadian Rhythm Support Interventions to Prevent Worsening of Depressive Symptoms: A Randomized Controlled TrialJeanne Leerssen, Oti Lakbila-Kamal, Laura M S Dekkers, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 2, 2001
A soluble class II cytokine receptor, IL-22RA2, is a naturally occurring IL-22 antagonistW Xu, S R Presnell, J Parrish-Novak, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 30, 2021
Clinical Activity of Single-Agent Cabozantinib (XL184), a Multi-receptor Tyrosine Kinase Inhibitor, in Patients with Refractory Soft-Tissue SarcomasGeraldine O'Sullivan Coyne, Shivaani Kummar, James Hu, et al.
Kidney Medicine|August 1, 2020
Development and Validation of Residual Kidney Function Estimating Equations in Dialysis PatientsDominik Steubl, Li Fan, Wieneke M Michels, et al.
Leukemia|January 5, 2020
Immunomodulation with pomalidomide at early lymphocyte recovery after induction chemotherapy in newly diagnosed AML and high-risk MDSJoshua F Zeidner, Hanna A Knaus, Amer M Zeidan, et al.
Blood Advances|January 26, 2021
Comparison of CALGB 10403 (Alliance) and COG AALL0232 toxicity results in young adults with acute lymphoblastic leukemiaAnjali S Advani, Eric Larsen, Kristina Laumann, et al.
Pageof 128